BERLIN, Sept. 9, 2024 /PRNewswire/ -- The Internationale Funkausstellung Berlin (IFA), the top-tier international tech fair, opened in Berlin, Germany from September 6th to 10th. Coinciding with the 100th anniversary of IFA, Yadea, the world's largest electric two-wheeler brand, makes another appearance with its flagship electric bikes, electric scooters, and cutting-edge green riding technology, impressing the visitors and industry with its strong brand presence and product innovation.
At the show, Yadea delivered its high-quality kick scooters in Booth 2.2-310, including the ElitePrime, EliteMax, Artist, and KS6 Pro models, all ideal for city commuting and embodying a sustainable, eco-friendly lifestyle. It's worth mentioning that ElitePrime is equipped with advanced shock absorption and a maximum power output of 1500W, which can deliver a swift and smooth ride. Besides, its self-healing tubeless tires can be quickly filled with self-healing technology for seamless repairs when it comes to nail damage.
Another standout electric bike model, the Trooper01, is equally impressive. Equipped with a 250W motor, the Trooper01 features dual suspension and wide tires for enhanced road handling, and its retro motorcycle design has gained significant popularity among young international users. And it has been tested and certified by the esteemed TUV SUD laboratory, meeting the EN15194 safety standard, which makes it a highly reliable electric bike for the European market.
This year, Yadea's participation at IFA goes beyond just showcasing its latest products. The brand is leveraging the event as a strategic platform to explore new opportunities for business collaboration. By fostering relationships with international distributors and retailers, Yadea aims to further establish itself as a leading player in the sustainable mobility sector.
Yadea continues to lead the electric two-wheeler market, maintaining the top sales spot for seven consecutive years. All products on display meet strict European certification standards, and the company has earned recognition for its innovation in green mobility, holding over 1,900 patents, two national CNAS laboratories, and six R&D centers. Yadea's strategic global expansion is further supported by its eight production bases, including key facilities in Indonesia and Vietnam, catering to its growing international footprint.
As the global demand for sustainable transportation grows, Yadea's commitment to green mobility remains at the forefront of its mission. With its pioneering technology and dedication to reducing carbon emissions, the company continues to make significant strides toward a cleaner, more environmentally friendly future.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Yadea Showcases Advanced Electric Two-Wheelers at IFA Berlin 2024, Leading the Way in Sustainable Mobility
The global launch brings image-based morphology intelligence into routine hematology workflows through AI × CBM technology.
FRANKFURT, Germany and ANAHEIM, Calif., July 29, 2026 /PRNewswire/ -- Ozelle has officially launched O-Cyte 1, its newest automated hematology analyzer, at ADLM 2026 in Anaheim, California. Built on AI × CBM (Complete Blood Morphology), O-Cyte 1 marks an important step in Ozelle's vision for the 4th Generation of Hematology Analysis, combining morphology intelligence, productivity, and operational simplicity in a compact hematology system.
Modern hematology systems already provide fast, reliable, and highly automated blood cell analysis. As clinical workloads continue to grow, however, laboratories are seeking new ways to bring morphology information into routine workflows with greater consistency, visibility, and operational efficiency.
O-Cyte 1 is designed for this next stage of hematology analysis. Rather than replacing existing laboratory expertise, the system adds an image-based morphology layer to automated hematology workflows. Through AI × CBM, cell images are transformed into structured morphology insight, helping laboratories access visible cellular evidence alongside routine hematology results.
The system supports up to 60 tests per hour as a standalone unit and up to 360 tests per hour with cascaded expansion, allowing laboratories to expand capacity as workload increases. Its compact design, consumable-contained fluidics, modular architecture, and service-ready design are intended to reduce daily maintenance burden and support flexible deployment across laboratories, hospitals, health screening centers, and regional diagnostic networks.
Alongside O-Cyte 1, Ozelle also presented its expanding clinical hematology portfolio at ADLM 2026, including integrated multi-test diagnostic systems combining hematology, immunoassay, and biochemistry capabilities, as well as compact 7-Diff hematology analyzers with cell imaging and simplified maintenance. Together, the portfolio reflects Ozelle's commitment to supporting different hematology testing environments with practical, scalable, and AI-powered diagnostic solutions.
The launch of O-Cyte 1 also reflects a broader shift in Ozelle's approach to diagnostics: from standalone instruments toward integrated systems designed for real-world clinical environments. By combining advanced imaging, AI-powered interpretation, automation, and maintenance-efficient design, Ozelle aims to make morphology intelligence more accessible, consistent, and scalable across diverse clinical settings.
Following its global debut at ADLM 2026, Ozelle will continue engaging with laboratories, healthcare organizations, and strategic partners worldwide to share more about O-Cyte 1 and explore collaboration opportunities in AI-powered hematology.
To learn more or schedule a product briefing, please visit: https://forms.gle/HWkFmcpzPW2WTM7x9
Contact Ozelle
www.ozellemed.com
info@ozellepoct.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology
Ozelle Launches O-Cyte 1 at ADLM 2026, Marking a New Step in AI-Powered Hematology
